Blog

Pam Mangat-Dhaliwal: Join us for a virtual Grand Rounds on May 6, 2024 to learn the latest from the TAPUR Study

Photo taken from Pam Mangat-Dhaliwal/LinkedIn

Apr 27, 2024, 08:10

Pam Mangat-Dhaliwal: Join us for a virtual Grand Rounds on May 6, 2024 to learn the latest from the TAPUR Study

Pam Mangat-Dhaliwal, Division Director of Clinical Research and Analytics at ASCO, shared on LinkedIn:

“Join us for a virtual Grand Rounds on May 6, 2024 to learn the latest from the TAPUR Study, an ongoing clinical trial investigating targeted therapies for advanced cancer. Speakers include: Richard Schilsky, Pam Mangat-Dhaliwal, Janet Freeman-Daily, Jens Rueter, and Gina Grantham.”

Additional information.
Source: Pam Mangat-Dhaliwal/LinkedIn

advanced cancer American Society of Clinical Oncology ASCO cancer clinical trial Gina Grantham Grand Rounds Janet Freeman-Daily Jens Rueter OncoDaily Oncology Pam Mangat-Dhaliwal Richard Schilsky TAPUR study Targeted Agent and Profiling Utilization Registry targeted therapies

New Paper Alert: Management of Immune Checkpoint Inhibitor-Associated Toxicities in Older Adults with Cancer

Kimryn Rathmell was Awarded 2025 ACS Medal of Honor

VERITAC-2 Trial Update: Vepdegestrant Meets Primary Endpoint in ESR1-Mutant Breast Cancer

New Paper Alert: HARMONi-2 study of Ivonescimab vs pembrolizumab for PD-L1-positive non-small cell lung cancer

We are thrilled to welcome Dr. Jasmine Kamboj to the OncoDaily Editorial Board!